- Home
- ASND vs GRAB Comparison
ASND vs GRAB Comparison
Compare ASND & GRAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASND | GRAB |
|---|---|---|
| Founded | 2006 | 2012 |
| Country | Denmark | Singapore |
| Employees | N/A | 12012 |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.5B | 14.4B |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | ASND | GRAB |
|---|---|---|
| Price | $210.87 | $3.37 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 16 | 4 |
| Target Price | ★ $281.50 | $6.53 |
| AVG Volume (30 Days) | 532.4K | ★ 40.0M |
| Earning Date | 05-12-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $96.35 | $24.04 |
| Revenue Next Year | $44.91 | $20.98 |
| P/E Ratio | ★ N/A | $74.17 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $161.09 | $3.38 |
| 52 Week High | $250.74 | $6.62 |
Technical Indicators
Market Signals| Indicator | ASND | GRAB |
|---|---|---|
| Relative Strength Index (RSI) | 33.76 | 35.23 |
| Support Level | $190.56 | N/A |
| Resistance Level | $218.88 | $3.95 |
| Average True Range (ATR) | 8.26 | 0.13 |
| MACD | -3.26 | -0.01 |
| Stochastic Oscillator | 0.19 | 2.64 |
Price Performance
Historical ComparisonAbout ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.
About GRAB Grab Holdings Limited
Founded in 2012, Grab provides ride-sharing services, food and grocery delivery, and financial services (payments, consumer loans, and enterprise offerings) in eight Southeast-Asian countries through its mobile platform. The company partners with merchants and riders, connecting them with consumers while charging commission to both sides. Grab has a leading market share in and derives 89% of its revenue from its core businesses, ride-sharing and food delivery. Singapore, Indonesia, and Malaysia contributed more than 70% of revenue in 2024. Grab's main competitors in Southeast Asia are Line Man and Goto. Its financial services business is still in its nascent stage and provides minimal revenue currently. The company now also generates advertising revenue.